Persistent Asset Partners Ltd
Sector Allocation
- Technology41.1%$130.4M
- Healthcare31.1%$98.6M
- Financials7.8%$24.6M
- Industrials5.9%$18.7M
- Materials5.7%$18.1M
- Consumer Discretionary4.8%$15.3M
- Energy1.1%$3.6M
- Communication Services1.0%$3.1M
- Other0.5%$1.7M
- Consumer Staples0.5%$1.5M
AUM History
13fpro.ai/research/fund/persistent-asset-partners-ltd-2056052
Conviction and streaks
Concentrating · top 10 = 36.7%From the fund's last 12 quarters of 13F filings: positions held longest at size, and names it added to or trimmed several quarters running.
Largest positions — Q2 2026
INTC
$24.2MHOOD
$19.2MSTM
$16.9MAPH
$13.3MSTX
$8.9MUTHR
$7.6MRVMD
$7.3MSNOW
$7.1MF
$6.2MABVX
$5.9MAMAT
$5.6MCOGT
$5.4MKLAC
$5.0MBMRN
$4.6MVKTX
$4.4MCDNS
$4.2MLRCX
$3.8MSMTC
$3.5MHON
$3.5MHONA
$3.4M
Top 20 stock positions. Options are left out: 13F reports them at the underlying's value.
13fpro.ai/research/fund/persistent-asset-partners-ltd-2056052
Persistent Asset Partners Ltd 13F holdings — Q2 2026
$335.1M portfolio (+24.9% QoQ) · 818 holdings · Q2 2026 13F · top 10 are 37% of the stock portfolio
Includes $18.2M of put/call options ($2.1M puts, $16.1M calls), which 13F rules report at the value of the underlying shares, not the premium at risk. Stocks alone: $317.0M. Weights use the stock portfolio.
$24.2M
7.6% of stocks
-37%This quarter-11.0%Since filed6 qtrsHeld$19.2M
6.0% of stocks
NewThis quarter-0.5%Since filedNew this quarterHeld$16.9M
5.3% of stocks
NewThis quarter-19.4%Since filedNew this quarterHeld$13.3M
4.2% of stocks
NewThis quarter-11.0%Since filedNew this quarterHeld$8.9M
2.8% of stocks
NewThis quarter-20.7%Since filedNew this quarterHeld$7.6M
2.4% of stocks
+103%This quarter+10.0%Since filed3 qtrsHeldAIQualityAI quality score is Pro: unlock with a free trialEst. buyEstimated buy price is Pro: unlock with a free trialAdded 3 qtrs in a row$7.3M
2.3% of stocks
+49%This quarter-10.4%Since filed5 qtrsHeldAIQualityAI quality score is Pro: unlock with a free trialEst. buyEstimated buy price is Pro: unlock with a free trialAdded 3 qtrs in a row$7.1M
2.2% of stocks
NewThis quarter+1.4%Since filedNew this quarterHeld$6.2M
2.0% of stocks
NewThis quarter-17.2%Since filedNew this quarterHeld$5.9M
1.9% of stocks
+94%This quarter-33.9%Since filed4 qtrsHeld
All holdings — Persistent Asset Partners Ltd (Q2 2026)
818 disclosed positions from the Form 13F-HR on SEC EDGAR, with quarter-over-quarter share changes. Largest by value first; the ten above are not repeated.
| # | Company | Held | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 11 | APPLIED MATERIALS INC /DE | Technology | $5.6M | 1.8% | 7,780 | New | 1 qtr | AI quality score is Pro: unlock with a free trial | 13F | |
| 12 | Cogent Biosciences, Inc. | Healthcare | $5.4M | 1.7% | 138K | +49% | 7+ qtrsAdded 3 qtrs in a row | AI quality score is Pro: unlock with a free trial | 13F | |
| 13 | KLA CORP | Technology | $5.0M | 1.6% | 16K | New | 1 qtr | AI quality score is Pro: unlock with a free trial | 13F | |
| 14 | BIOMARIN PHARMACEUTICAL INC | Healthcare | $4.6M | 1.4% | 80K | +113% | 7+ qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 15 | Viking Therapeutics, Inc. | Healthcare | $4.4M | 1.4% | 113K | -15% | 6 qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 16 | CADENCE DESIGN SYSTEMS INC | Technology | $4.2M | 1.3% | 11K | New | 1 qtr | AI quality score is Pro: unlock with a free trial | 13F | |
| 17 | LAM RESEARCH CORP | Technology | $3.8M | 1.2% | 8,824 | New | 1 qtr | AI quality score is Pro: unlock with a free trial | 13F | |
| 18 | SEMTECH CORP | Technology | $3.5M | 1.1% | 22K | -30% | 2 qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 19 | HONEYWELL INTERNATIONAL INC | Industrials | $3.5M | 1.1% | 15K | New | 1 qtr | AI quality score is Pro: unlock with a free trial | 13F | |
| 20 | Honeywell Aerospace Inc. | Industrials | $3.4M | 1.1% | 15K | New | 1 qtr | AI quality score is Pro: unlock with a free trial | 13F | |
| 21 | WESTERN DIGITAL CORP | Technology | $3.1M | 1.0% | 4,859 | New | 1 qtr | AI quality score is Pro: unlock with a free trial | 13F | |
| 22 | Sandisk Corp | Technology | $3.1M | 1.0% | 1,360 | -90% | 3 qtrsTrimmed 2 qtrs in a row | AI quality score is Pro: unlock with a free trial | 13F | |
| 23 | Edgewise Therapeutics, Inc. | Healthcare | $2.8M | 0.9% | 69K | +591% | 3 qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 24 | LITTELFUSE INC /DE | Technology | $2.7M | 0.8% | 5,927 | New | 1 qtr | AI quality score is Pro: unlock with a free trial | 13F | |
| 25 | CORNING INC /NY | Materials | $2.4M | 0.8% | 9,368 | -84% | 3 qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 26 | $MU | MICRON TECHNOLOGY INC | Technology | $2.4M | 0.8% | 2,053 | -88% | |||
| 27 | $VKTX CALL | Viking Therapeutics, Inc. | Healthcare | $2.3M | — | 3,105 | +86% | |||
| 28 | $ONTO | ONTO INNOVATION INC. | Technology | $2.3M | 0.7% | 5,947 | New | |||
| 29 | $KOD | Kodiak Sciences Inc. | Healthcare | $2.2M | 0.7% | 56K | +9% | |||
| 30 | $TRIP | TripAdvisor, Inc. | Technology | $2.2M | 0.7% | 158K | +58% | |||
| 31 | $PDD | PDD Holdings Inc. | Consumer Discretionary | $2.1M | 0.7% | 28K | +91% | |||
| 32 | $AEIS | ADVANCED ENERGY INDUSTRIES INC | Technology | $2.1M | 0.7% | 5,747 | New | |||
| 33 | $NXE | NexGen Energy Ltd. | Materials | $2.1M | 0.7% | 227K | -5% | |||
| 34 | $EGO | ELDORADO GOLD CORP /FI | Materials | $2.1M | 0.7% | 67K | +28% | |||
| 35 | $ENTG | ENTEGRIS INC | Materials | $2.1M | 0.7% | 12K | New | |||
| 36 | $IMCR | Immunocore Holdings plc | Healthcare | $2.1M | 0.7% | 65K | +33% | |||
| 37 | $ABVX CALL | Abivax S.A. | Healthcare | $2.1M | — | 890 | +252% | |||
| 38 | $PGEN | PRECIGEN, INC. | Healthcare | $2.0M | 0.6% | 356K | +2445% | |||
| 39 | $BTDR | Bitdeer Technologies Group | Financials | $2.0M | 0.6% | 125K | +35% | |||
| 40 | $NBIS | Nebius Group N.V. | Technology | $2.0M | 0.6% | 7,153 | -61% | |||
| 41 | $FDMT | 4D Molecular Therapeutics, Inc. | Healthcare | $1.9M | 0.6% | 146K | New | |||
| 42 | $AMCR | Amcor plc | Consumer Discretionary | $1.9M | 0.6% | 43K | +45% | |||
| 43 | $NAVN | Navan, Inc. | Technology | $1.8M | 0.6% | 80K | New | |||
| 44 | $RCUS | Arcus Biosciences, Inc. | Healthcare | $1.8M | 0.6% | 57K | -5% | |||
| 45 | $MKSI | MKS INC | Technology | $1.6M | 0.5% | 3,577 | +588% | |||
| 46 | $CORT CALL | CORCEPT THERAPEUTICS INC | Healthcare | $1.6M | — | 524 | +31% | |||
| 47 | $EXE | EXPAND ENERGY Corp | Energy | $1.5M | 0.5% | 17K | +31% | |||
| 48 | $TGB | Trekor Metals Ltd | Materials | $1.5M | 0.5% | 214K | -7% | |||
| 49 | $TRMD | TORM plc | Industrials | $1.5M | 0.5% | 56K | New | |||
| 50 | $JNJ | JOHNSON & JOHNSON | Healthcare | $1.4M | 0.5% | 5,605 | -59% | |||
| 51 | $HBM | Hudbay Minerals Inc. | Materials | $1.4M | 0.4% | 59K | New | |||
| 52 | $CMBT | CMB.TECH NV | Industrials | $1.4M | 0.4% | 97K | -13% | |||
| 53 | $GLNG | GOLAR LNG LTD | Industrials | $1.3M | 0.4% | 27K | New | |||
| 54 | $RLAY | Relay Therapeutics, Inc. | Healthcare | $1.3M | 0.4% | 71K | +332% | |||
| 55 | $NVO | NOVO NORDISK A S | Healthcare | $1.2M | 0.4% | 26K | +595% | |||
| 56 | $EQX | Equinox Gold Corp. | Materials | $1.2M | 0.4% | 123K | +3% | |||
| 57 | $DOCN | DigitalOcean Holdings, Inc. | Technology | $1.2M | 0.4% | 7,550 | New | |||
| 58 | $SHOP | SHOPIFY INC. | Technology | $1.1M | 0.4% | 10K | New | |||
| 59 | $CRVS | Corvus Pharmaceuticals, Inc. | Healthcare | $1.1M | 0.3% | 75K | +21% | |||
| 60 | $SMWB | SIMILARWEB LTD. | Technology | $1.1M | 0.3% | 180K | — | |||
| 61 | $ECO | Okeanis Eco Tankers Corp. | Industrials | $1.1M | 0.3% | 22K | New | |||
| 62 | $KYMR CALL | Kymera Therapeutics, Inc. | Healthcare | $1.0M | — | 381 | New | |||
| 63 | $INDV | Indivior Pharmaceuticals, Inc. | Healthcare | $1.0M | 0.3% | 25K | +38% | |||
| 64 | $CGAU | Centerra Gold Inc. | Materials | $1.0M | 0.3% | 63K | New | |||
| 65 | $IVZ | Invesco Ltd. | Financials | $993K | 0.3% | 4,667 | New | |||
| 66 | $QURE CALL | uniQure N.V. | Healthcare | $983K | — | 596 | -7% | |||
| 67 | $ZYME | Zymeworks Inc. | Healthcare | $939K | 0.3% | 36K | — | |||
| 68 | $BIOA | BioAge Labs, Inc. | Healthcare | $913K | 0.3% | 37K | +146% | |||
| 69 | $TSHA | Taysha Gene Therapies, Inc. | Healthcare | $909K | 0.3% | 133K | New | |||
| 70 | $PCVX | Vaxcyte, Inc. | Healthcare | $878K | 0.3% | 15K | +184% | |||
| 71 | $CPNG | Coupang, Inc. | Consumer Discretionary | $870K | 0.3% | 50K | New | |||
| 72 | $SLS CALL | SELLAS Life Sciences Group, Inc. | Healthcare | $853K | — | 1,013 | +34% | |||
| 73 | $CSIQ | Canadian Solar Inc. | Technology | $851K | 0.3% | 53K | +6% | |||
| 74 | $PSIX | POWER SOLUTIONS INTERNATIONAL, INC. | Industrials | $850K | 0.3% | 22K | +409% | |||
| 75 | $GLUE | Monte Rosa Therapeutics, Inc. | Healthcare | $825K | 0.3% | 34K | -28% | |||
| 76 | $CRH | CRH PUBLIC LTD CO | Materials | $822K | 0.3% | 7,678 | -32% | |||
| 77 | $Q | Qnity Electronics, Inc. | Technology | $791K | 0.3% | 4,844 | -5% | |||
| 78 | $IVA | Inventiva S.A. | Healthcare | $791K | 0.3% | 209K | +63% | |||
| 79 | $BTG | B2GOLD CORP | Materials | $781K | 0.3% | 209K | New | |||
| 80 | $SYRE | Spyre Therapeutics, Inc. | Healthcare | $778K | 0.3% | 8,760 | +82% | |||
| 81 | $LPG | DORIAN LPG LTD. | Industrials | $774K | 0.2% | 22K | New | |||
| 82 | $AZN | ASTRAZENECA PLC | Healthcare | $769K | 0.2% | 4,058 | +228% | |||
| 83 | $NRIX | Nurix Therapeutics, Inc. | Healthcare | $751K | 0.2% | 31K | New | |||
| 84 | $CRBP | Corbus Pharmaceuticals Holdings, Inc. | Healthcare | $722K | 0.2% | 77K | -31% | |||
| 85 | $MRVL | Marvell Technology, Inc. | Technology | $721K | 0.2% | 2,421 | -84% | |||
| 86 | $VERA | Vera Therapeutics, Inc. | Healthcare | $707K | 0.2% | 16K | New | |||
| 87 | $FSLR | FIRST SOLAR, INC. | Technology | $702K | 0.2% | 3,013 | -5% | |||
| 88 | $CAPR CALL | CAPRICOR THERAPEUTICS, INC. | Healthcare | $697K | — | 831 | — | |||
| 89 | $ORKA | Oruka Therapeutics, Inc. | Healthcare | $674K | 0.2% | 7,085 | New | |||
| 90 | $DFTX | Definium Therapeutics, Inc. | Healthcare | $648K | 0.2% | 14K | -13% | |||
| 91 | $GH | Guardant Health, Inc. | Healthcare | $641K | 0.2% | 4,275 | +5% | |||
| 92 | $DAR | DARLING INGREDIENTS INC. | Consumer Staples | $633K | 0.2% | 12K | +23% | |||
| 93 | $PBF | PBF Energy Inc. | Energy | $632K | 0.2% | 14K | +112% | |||
| 94 | $SNY | Sanofi | Healthcare | $629K | 0.2% | 15K | +48% | |||
| 95 | $BE | Bloom Energy Corp | Technology | $622K | 0.2% | 2,054 | +738% | |||
| 96 | $TMO | THERMO FISHER SCIENTIFIC INC. | Healthcare | $619K | 0.2% | 1,235 | +146% | |||
| 97 | $SYK | STRYKER CORP | Healthcare | $604K | 0.2% | 1,918 | +73% | |||
| 98 | $RLMD | RELMADA THERAPEUTICS, INC. | Healthcare | $598K | 0.2% | 86K | +70% | |||
| 99 | $UNH | UNITEDHEALTH GROUP INC | Healthcare | $593K | 0.2% | 1,427 | New | |||
| 100 | $WGS | GeneDx Holdings Corp. | Healthcare | $587K | 0.2% | 8,555 | New | |||
| 101 | $IVZ | Invesco Ltd. | Financials | $575K | 0.2% | 7,680 | New | |||
| 102 | $AVBP | ArriVent BioPharma, Inc. | Healthcare | $547K | 0.2% | 16K | +94% | |||
| 103 | $DNTH | Dianthus Therapeutics, Inc. /DE/ | Healthcare | $543K | 0.2% | 5,571 | -25% | |||
| 104 | $CTNM | Contineum Therapeutics, Inc. | Healthcare | $541K | 0.2% | 33K | New | |||
| 105 | $RGEN | REPLIGEN CORP | Healthcare | $532K | 0.2% | 3,902 | New | |||
| 106 | $NOK | NOKIA CORP | Technology | $523K | 0.2% | 39K | New | |||
| 107 | $NKTR | NEKTAR THERAPEUTICS | Healthcare | $522K | 0.2% | 7,481 | +29% | |||
| 108 | $SMMT CALL | Summit Therapeutics Inc. | Healthcare | $520K | — | 2,194 | New | |||
| 109 | $PHAT | Phathom Pharmaceuticals, Inc. | Healthcare | $517K | 0.2% | 48K | +78% | |||
| 110 | $MIRM | Mirum Pharmaceuticals, Inc. | Healthcare | $516K | 0.2% | 4,404 | +23% | |||
| 111 | $ALM | Almonty Industries Inc. | Materials | $509K | 0.2% | 31K | New | |||
| 112 | $BCYC | BICYCLE THERAPEUTICS PLC | Healthcare | $497K | 0.2% | 117K | -3% | |||
| 113 | $ALKS | Alkermes plc. | Healthcare | $489K | 0.1% | 9,338 | -63% | |||
| 114 | $FLGT | Fulgent Genetics, Inc. | Healthcare | $488K | 0.1% | 24K | New | |||
| 115 | $TENX CALL | TENAX THERAPEUTICS, INC. | Healthcare | $481K | — | 782 | New | |||
| 116 | $LQDA | Liquidia Corp | Healthcare | $479K | 0.1% | 6,005 | New | |||
| 117 | $ELVN | Enliven Therapeutics, Inc. | Healthcare | $479K | 0.1% | 9,433 | +43% | |||
| 118 | $TRVI | Trevi Therapeutics, Inc. | Healthcare | $477K | 0.1% | 26K | -8% | |||
| 119 | $MANE | Veradermics, Inc | Healthcare | $469K | 0.1% | 3,811 | -59% | |||
| 120 | $VRDN | Viridian Therapeutics, Inc.\DE | Healthcare | $468K | 0.1% | 25K | New | |||
| 121 | $CYTK | CYTOKINETICS INC | Healthcare | $455K | 0.1% | 5,346 | New | |||
| 122 | $AVTX | Avalo Therapeutics, Inc. | Healthcare | $454K | 0.1% | 25K | +210% | |||
| 123 | $ALMS CALL | ALUMIS INC. | Healthcare | $444K | — | 508 | +101% | |||
| 124 | $NWS | NEWS CORP | Communication Services | $444K | 0.1% | 16K | -53% | |||
| 125 | $MGNX | MACROGENICS INC | Healthcare | $441K | 0.1% | 95K | -37% | |||
| 126 | $PRQR | ProQR Therapeutics N.V. | Healthcare | $440K | 0.1% | 236K | +413% | |||
| 127 | $EW | Edwards Lifesciences Corp | Healthcare | $438K | 0.1% | 4,846 | -30% | |||
| 128 | $LNTH | Lantheus Holdings, Inc. | Healthcare | $433K | 0.1% | 3,903 | +48% | |||
| 129 | $ABT | ABBOTT LABORATORIES | Healthcare | $433K | 0.1% | 4,770 | -30% | |||
| 130 | $BHVN CALL | Biohaven Ltd. | Healthcare | $424K | — | 806 | — | |||
| 131 | $UNCY | Unicycive Therapeutics, Inc. | Healthcare | $423K | 0.1% | 90K | +236% | |||
| 132 | $SPRB | SPRUCE BIOSCIENCES, INC. | Healthcare | $415K | 0.1% | 7,677 | +204% | |||
| 133 | $AVR | Anteris Technologies Global Corp. | Healthcare | $413K | 0.1% | 42K | -51% | |||
| 134 | $CAPR PUT | CAPRICOR THERAPEUTICS, INC. | Healthcare | $405K | — | 1,356 | -14% | |||
| 135 | $REPL CALL | Replimune Group, Inc. | Healthcare | $397K | — | 1,774 | +241% | |||
| 136 | $AVGO | Broadcom Inc. | Technology | $396K | 0.1% | 1,048 | New | |||
| 137 | $ARDX | ARDELYX, INC. | Healthcare | $395K | 0.1% | 77K | New | |||
| 138 | $QURE | uniQure N.V. | Healthcare | $394K | 0.1% | 8,545 | +8% | |||
| 139 | $AA | Alcoa Corp | Materials | $391K | 0.1% | 7,507 | New | |||
| 140 | $ROIV | Roivant Sciences Ltd. | Healthcare | $390K | 0.1% | 11K | New | |||
| 141 | $CUE | Cue Biopharma, Inc. | Healthcare | $389K | 0.1% | 12K | -63% | |||
| 142 | $MLYS | Mineralys Therapeutics, Inc. | Healthcare | $389K | 0.1% | 14K | -6% | |||
| 143 | $FBRX | Forte Biosciences, Inc. | Healthcare | $388K | 0.1% | 18K | +171% | |||
| 144 | $AXSM | Axsome Therapeutics, Inc. | Healthcare | $385K | 0.1% | 1,573 | New | |||
| 145 | $ERAS | Erasca, Inc. | Healthcare | $377K | 0.1% | 21K | -27% | |||
| 146 | — | PROTHENA CORP PLC - SHS | — | $373K | 0.1% | 38K | New | |||
| 147 | $TDS | TELEPHONE & DATA SYSTEMS INC /DE/ | Communication Services | $368K | 0.1% | 9,948 | New | |||
| 148 | $VYGR | Voyager Therapeutics, Inc. | Healthcare | $366K | 0.1% | 105K | -2% | |||
| 149 | $COR | Cencora, Inc. | Consumer Staples | $357K | 0.1% | 1,260 | +4% | |||
| 150 | $OCS | Oculis Holding AG | Healthcare | $355K | 0.1% | 26K | New |
What changed in Q2 2026
Against the previous quarter's 13F: 626 new, 73 added to, 94 trimmed, 131 sold out. Share-count changes; largest moves by dollar size first.
New positions (626)
$HOODRobinhood Markets, Inc.$19.2M
first bought this quarter
$STMSTMicroelectronics N.V.$16.9M
first bought this quarter
$APHAMPHENOL CORP /DE/$13.3M
first bought this quarter
$STXSeagate Technology Holdings plc$8.9M
first bought this quarter
$SNOWSnowflake Inc.$7.1M
first bought this quarter
$FFORD MOTOR CO$6.2M
first bought this quarter
+620 more in the Excel export
Added to (73)
$UTHRUNITED THERAPEUTICS Corp+103%
now $7.6M · held 3 qtrs, 3 adds in a row
$ABVXAbivax S.A.+94%
now $5.9M · held 4 qtrs
$BMRNBIOMARIN PHARMACEUTICAL INC+113%
now $4.6M · held 7+ qtrs
$EWTXEdgewise Therapeutics, Inc.+591%
now $2.8M · held 3 qtrs
$RVMDRevolution Medicines, Inc.+49%
now $7.3M · held 5 qtrs, 3 adds in a row
$PGENPRECIGEN, INC.+2445%
now $2.0M · held 2 qtrs, 2 adds in a row
+67 more in the Excel export
Trimmed (94)
$SNDKSandisk Corp-90%
now $3.1M · held 3 qtrs, 2 trims in a row
$MUMICRON TECHNOLOGY INC-88%
now $2.4M · held 3 qtrs
$ALABAstera Labs, Inc.-100%
now $77K
$INTCINTEL CORP-37%
now $24.2M · held 6 qtrs
$GLWCORNING INC /NY-84%
now $2.4M · held 3 qtrs
$NVDANVIDIA CORP-99%
now $109K
+88 more in the Excel export
Sold out (131)
$LITELumentum Holdings Inc.was $14.5M
held 2 qtrs
$AXTIAXT INCwas $13.3M
held 2 qtrs
$TSEMTOWER SEMICONDUCTOR LTDwas $11.9M
held 1 qtr
$TSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDwas $4.2M
held 2 qtrs
$MTSIMACOM Technology Solutions Holdings, Inc.was $3.5M
held 1 qtr
$COHRCOHERENT CORP.was $3.3M
+125 more in the Excel export
Holdings by quarter
Every 13F Persistent Asset Partners Ltd has filed, 6 earlier quarters. Pick one to see what it held then.
Is it too late to follow Persistent Asset Partners Ltd?
Q2 2026 13F filed with the SEC on Aug 7, 2026. Prices are closing prices as of Oct 26, 2026.
Average quality of Persistent Asset Partners Ltd's top 20 holdings: 66/100 (our AI quality score, weighted by position size; 13 of the 20 are scored)
Top 10 since filing
-10.6%
Value-weighted move of the 10 largest stock positions
Turnover
71%
Last quarter; 217% over the last 4
Top 10 weight
37%
Share of the stock portfolio in its 10 largest positions
Held 4+ quarters
23%
Share of portfolio value in positions held a year or more
Highest-quality names it owns(among its 100 largest positions)
The 8 highest-scoring companies in this portfolio are a Pro feature.
How these are measured
- Moves since the quarter-end and since the filing date use our own daily closing prices, from the close on (or just before) each date to the latest close.
- Turnover is the lesser of shares bought or sold in a quarter, valued at the quarter-end prices in the 13F, divided by the average of the two quarters' stock portfolio values.
- Quarters held and add/trim streaks count back only through quarters whose filed holdings add up to the filing's own cover-page total (back to Q4 2024 for this fund). A change counts as an add or a trim when the split-adjusted share count moves by more than 1%.
- Estimate, not the fund's reported cost. For each quarter in the current holding period in which the fund's share count rose (split-adjusted), we take that quarter's average daily close and weight it by the shares added; sales do not change an average cost. Quarters where the stock's price history and the 13F's own implied price disagree by more than 2x are left out.
- Put and call option rows report the value of the underlying shares, not a position the fund paid for, so they are left out of all of the above.
Portfolio Overview
Persistent Asset Partners Ltd disclosed 818 positions worth $335.1M in its Form 13F-HR for Q2 2026 — $317.0M in common stock plus $18.2M of put/call option positions (reported at underlying notional value, not premium at risk), led by $INTC (INTEL CORP) at 7.6% of the equity portfolio, followed by $HOOD and $STM. During the quarter the fund opened 626 new positions and exited 131 — including a new stake in $HOOD and a full exit from $LITE. The portfolio is most concentrated in Technology (41.1% of disclosed assets). All figures are sourced directly from Persistent Asset Partners Ltd’s Form 13F-HR filing with the SEC under CIK 2056052.
Funds like this
managers whose biggest positions overlap Persistent Asset Partners Ltd'sBrowse Top Institutional Investors
13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.
to search all 8,700+ institutional filers.
AI-Powered Hedge Fund Analysis: Persistent Asset Partners Ltd
13F Pro is an AI hedge fund tracker and stock research platform. For Persistent Asset Partners Ltd (SEC CIK: 2056052), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.
Every holding in Persistent Asset Partners Ltd's portfolio is scored on an AI quality ranking built from its SEC filings (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.